Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker

Nuclear Medicine and Biology

Volumn 28, Issue 1, 2001, Pages 59-65

  Gudjonssona, Olafur ^a   Bergström, Mats ^b   Kristjansson, Stefan ^b,c   Wu, Feng ^b   Nyberg, Gunnar ^a   Fasth, Karl Johan ^b   Långström, Bengt ^b  

^a Department of Neurosurgery ^*  (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain tumors; BrdU; DNA synthesis; Positron emission tomography; Proliferation

Indexed keywords

BROMIDE 76; BROMODEOXYURIDINE BR 76; BROXURIDINE; DNA; RADIOISOTOPE; TRACER; UNCLASSIFIED DRUG; BROMINE; RADIOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL FRACTIONATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; METASTASIS; OLIGODENDROGLIOMA; PARENCHYMA; PLASMA; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; BLOOD; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTISCANNING;

AGED; ASTROCYTOMA; BRAIN NEOPLASMS; BROMINE RADIOISOTOPES; BROMODEOXYURIDINE; DNA, NEOPLASM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034746234     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00193-1     Document Type: Article

References (25)

1. A rapid and accurate method to realign PET scans utilizing image edge information
2. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker
3. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET
4. [Methyl-carbon-11] thymidine for in vivo measurement of cell proliferation
5. Measurement of [methyl-carbon-11] thymidine and its metabolites in head and neck tumors
6. Synthesis of 6-methyl[11C]-2′-deoxyuridine and evaluation of its in vivo distribution in Wistar rats
7. Monoclonal antibody to 5-bromo- and iododeoxyuridine: A new reagent for detection of DNA replication
8. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas
9. Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time
10. The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidne in man
11. Performance characteristics of an eight-ring whole body PET scanner
12. Synthesis of L- and D-[methyl-11C]methionine
13. PET-study of intracranial meninglomas: Correlation with histopathology, cellularity and proliferation rate
14. 76Br]Bromodeoxyuridine
15. Recurrence of cranial base meningiomas
16. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues
17. Clinical positron emission tomography for brain tumors: Comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine
18. Extracellular water measurements: Organ tracer kinetics of bromide and sucrose in rats and man
19. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections
20. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas-comparison with gliomas
21. Pharmacokinetics of oral and intravenous bromide in normal volunteers
22. Measurement of short-term 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET)
23. Brain tumor imaging with PET and 2-[carbon-11]thymidine